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Abstract
Lang, Katie Patricia. Ph.D. The University of Memphis. August, 2015. CBT
Group Intervention to Increase CPAP Adherence among Veterans with Sleep Apnea: A
Pilot Investigation. Major Professor: Frank Andrasik, Ph.D.

Sleep Apnea (SA) is gaining increased attention among military populations due
to the increasing prevalence rates (40-60%) and risk of serious health complications (i.e.,
cognitive decline, stroke) when untreated. Unfortunately, adherence to Continuous
Positive Airway Pressure (CPAP; the gold standard treatment) is chronically low. This
study examined the efficacy of a 6-week CBT group intervention to increase CPAP
adherence among veterans diagnosed with SA and prescribed CPAP treatment. A final
sample of 35 veterans was randomly assigned either to treatment as usual (TAU) or TAU
plus the CBT group intervention. Participants completed various self-report measures and
a therapist-administered cognitive screening at baseline and a 3-month post-assessment.
On average the sample had severe SA, were obese, reported poor sleep quality, exhibited
significant daytime sleepiness, and reported clinically significant symptoms of PTSD
(59%), depression (62%), and anxiety (66%). Unfortunately, due to inconsistent and
invalid CPAP adherence reporting in participant’s medical charts, we were unable to
analyze this information. Veterans in the CPAP group condition reported a reduction in
their mental health symptoms at the post-assessment, with small to moderate effect sizes
(d = .20 to .50) compared to an increase in PTSD and anxiety symptoms among
participants in the TAU condition (effect sizes; d = .25 to .60). Attending the group also
appeared to reduce participants’ perceived risk of SA and improve their outcome
expectations and treatment self-efficacy. The cognitive screening measures suggested that
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the overall sample was functioning within the average range at baseline and no changes
were noted at the post-assessment. The present study was the first, to our knowledge, to
investigate the efficacy of a group intervention for CPAP adherence among a veteran
sample. The group intervention appeared to be well tolerated, with a lower dropout rate
than those reported in published CPAP intervention studies, and the majority of group
completers indicated that treatment “made things a lot better.” Barriers discovered
during the study highlight the necessity of transdisciplinary care that integrates mental
health with medical clinics to provide effective services to veterans. Possible future
directions are discussed in order to further develop this area of investigation and
treatment.
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Chapter 1
Introduction
Among the 2 million military personnel who have deployed to Iraq and
Afghanistan since 2001, commonly reported psychological and physical health
complications include PTSD, depression, mild traumatic brain injury (mTBI), and pain
(Hoge et al., 2008; Lang, Veazey-Morris, & Andrasik, 2014). However, prevalence of
sleep disorders among military personnel is steadily increasing (Seelig et al., 2010).
While some studies suggest that the increased incidence of sleep problems are symptoms
of primary disorders such as PTSD (McLay, Klam, & Volkert, 2010), research suggests
that up to 70% of service members may continue to experience disturbances in their sleep
following treatment of their primary disorders (Belleville, Guay, & Marchand, 2011;
Zayfert & DeViva, 2004). This indicates that sleep disorders are an important aspect of
the post-deployment health adjustment and deserve individual attention. One such sleep
disturbance is sleep apnea (SA), which has been reported in over 50% of active duty
service members (Mysliwiec et al., 2013). This sleep disorder has also gained recent
national attention for the dramatic increase in diagnosed cases among veterans since 9/11
(Philpott, 2013).
Rates of SA in the general population range from 2% to 7% with higher rates
found in men than women (Punjabi, 2008; Ram, Sierawan, Kumar, & Clark, 2010).
Among military personnel rates are considerably higher, ranging from 20% to 40% and
soaring to 62% in VA treatment seeking samples (Brook 2010; Eliasson, Kashani, Dela
Cruz, & Vernalis, 2012; Mysliwiec et al., 2013). Furthermore, studies suggest that up to
75% of cases of sleep disordered breathing at large, including SA, go undiagnosed (Ram
et al., 2010). The typically chronic nature of SA not only poses serious health threats and
1

disrupts quality of life but also places a significant financial burden on the Department of
Veterans Affairs (VA). Spending has topped $500 million a year to treat veterans with
the disorder (Brook, 2010); indicating a need to better understand and treat SA.
Three types of SA exist—obstructive, central, and mixed—and each results in
repetitive periods of cessation in breathing (apneas) or reductions in the amplitude of a
breath (hypopneas), that occur during sleep (Panossian & Daley, 2013). Obstructive sleep
apnea (OSA), the most common, is characterized by episodes of obstruction in the upper
airway during sleep that can last up to 60 s. In central SA the brain fails to signal the
muscles to breathe resulting in cessation of airflow and a reduction in respiratory effort
(Panossian, & Daley, 2013). Mixed SA is a combination of the two. Severity of SA is
measured with the apnea–hypopnea index (AHI), which is the mean number of apneas
and/or hypopneas per hour of sleep (Punjabi, 2008). The American Academy of Sleep
Medicine suggests SA be categorized as mild (AHI: 5-14), moderate (AHI: 15-30), and
severe (AHI: 31 and above) (AASM, 2005). Regardless of the type of SA, during the
apnea or hypopnea episode as the oxygen level in the blood drops, the individual is
awakened by a surge of sympathetic nervous system activity that triggers the body to
resume breathing (Collop, 2007). Some people experience 50 or more of these episodes
per hour as measured with a polysomnography (PSG) sleep study (Collop, 2007).
Symptoms and Health Complications
Physical symptoms of SA include snoring, choking or gasping during sleep,
insomnia, morning headache, and daytime sleepiness (Caples, Gami, & Somers, 2005).
From a population-based study, of those people who had been diagnosed with OSA, the
most common symptoms were snoring (48%), feeling unrested during the day (27%),
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excessive daytime sleepiness at least 5 days per month (19%), and stopping breathing at
least 3 nights per week (11%) (Ram et al., 2010). Other commonly reported problems
associated with sleep disordered breathing included marital discord, increased irritability
and depression, loss of sexual and social intimacy, loss of sleep by family members, and
family members’ worrying about the patient’s health (Smith et al., 1998). If left
untreated, chronic SA can lead to cognitive dysfunction, impaired work performance, and
reductions in health-related quality of life (Punjabi, 2008). In regard to quality of life,
Lopes and colleagues (2008) conducted a study of 1,384 patients diagnosed with OSA at
a sleep clinic and found that reduction in quality of life was proportional to SA severity.
Further, there was a significant decrease in all domains (physical functioning, role
physical problems, bodily pain, general health perceptions, vitality, social functioning,
emotional problems, and general mental health) for individuals with severe OSA.
The oxygen desaturation that occurs in OSA can also cause a myriad of health
problems. Chronic medical correlates of OSA include hypertension, stroke,
cardiovascular disease and even death (Collop, 2007). Yaggi et al. (2005) found that
across a 3-year study, people with SA had a 2-fold increased risk for either incident
stokes or death and this was independent of other cardiovascular risk factors. In one
population-based longitudinal study, cardiovascular mortality accounted for 42% of all
deaths in persons who had severe sleep disordered breathing at baseline, nearly twice the
rate among people without any sleep breathing problems (Young et al., 2008). Further, it
has been well documented that untreated OSA can affect executive cognitive functioning
including memory and vigilance (Kylstra, Aaronson, Hofman, & Schmand, 2013). One
reason for this is that our central nervous system is sensitive to hypoxemia (lack of
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oxygen). When oxygen is reduced in the brain, the resultant disruption of neurological
functioning can cause significant cognitive impairments (Ganong, 1981).
Complicating this picture of poor physical health is often co-occurring mental
health problems among people with OSA. From a large review of primarily civilian
samples, rates of comorbid depression ranged from 7-63% and anxiety from 11-70%
(Saunamäki & Jehkonen, 2007). This variability in prevalence is likely due to
discrepancies in study selection, patient characteristics, measures used to assess mood,
and overlap between mood alteration and OSA symptoms. Rates of comorbidity among
military populations appear to be more stable. Mysliwic and colleagues (2013) reviewed
the records of 725 active duty military personnel who completed a diagnostic PSG in
2010 to assess their comorbid mental health problems. The majority of the sample was
male and combat veterans with high rates of anxiety (16.8%), depression (22.6%), PTSD
(13.2%), and mTBI (12.8%) with 23% of the entire sample having a comorbid condition.
Further, individuals with combined OSA and insomnia were more likely to meet criteria
for comorbid mental health problems compared to controls having OSA only. Similarly,
in a review of VHA data from 1998- 2001, psychiatric disorders were more prevalent
among individuals with OSA compared to those without; the most common diagnoses
were depression (21%) and anxiety (16%) (Sharafkhaneh, Giray, Richardson, Young, &
Hirshkowitz, 2005).
Treatment and Adherence
The OSA Task Force for the American Academy of Sleep Medicine recommends
that OSA be approached as a chronic disease requiring long-term, multidisciplinary
management (Epstein et al., 2009). As the severity of OSA exists along a continuum, so
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does the intensity of treatment, which may include lifestyle/behavioral changes, medical,
and/or surgical options. The most common and most effective treatment for OSA
involves use of a continuous positive airway pressure (CPAP) device. This consists of a
mask worn snugly over the nose and/or mouth with a hose that is connected to a
compressor that emits a constant rate of air flow. This air flow splints the pharyngeal
airway space preventing the upper airway from collapsing during sleep; leading to
improved oxygenation and decreased sleep fragmentation (Epstein et al., 2009).
There is a general consensus across the literature that CPAP improves physical
health. A review by Barnes et al. (2004) concluded that individuals with severe SA who
received CPAP treatment reported a significant improvement in neuropsychological
functioning including vigilance and executive cognitive function. In a more recent metaanalysis, CPAP was found to be superior to positional therapy (i.e., using a pillow/wedge
to prevent supine sleeping position) in reducing severity of SA and increasing oxygen
saturation in patients (Ha, Hirai, & Tsoi, 2014). Among male patients with severe SA,
CPAP treatment has also been found to significantly reduce the risk of both fatal and
non-fatal cardiovascular events when compared to healthy controls matched for age and
body-mass-index (Marin, Carrizo, Vicente, & Agusti, 2005).
The literature is mixed as to the effect of CPAP treatment on mood. Saunasmaki
and Jehkonen’s (2007) efficacy review of CPAP studies with a minimum follow-up
period of 3 months found that depressive symptoms improved in four of seven studies
and anxiety symptoms improved in two of four studies. The authors concluded it is likely
that mental health problems are often secondary to OSA and adequate CPAP treatment
may improve depressive and anxious symptoms. However, studies examining the long-
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term effectiveness of CPAP on mood are few in number. Randomized trials have found
CPAP therapy to improve mood when compared to treatment as usual, to placebo tablet,
and to sham CPAP; suggesting a robust benefit (Sanchez, Martinez, Miro, Bardwell, &
Buela-Casal, 2009). Schwartz and Karatinos (2007) conducted a longitudinal study with
50 individuals who were evaluated with PSG and treated with CPAP adequately (> 6 hr
night, 7 nights a week). One hundred percent of participants who had an elevated
depression score at baseline reported a subclinical level of depression at the 6-week
follow-up and these gains were maintained throughout a one-year follow-up. What stands
out across studies is the likely reciprocal relationship between mood and OSA symptoms
that complicates diagnosis and treatment of each disorder (Ejaz, Khawaja, Bhatia, &
Hurwitz, 2011). In sum, CPAP therapy has the potential to improve neuropsychological
functioning, cardiovascular health, and mood when used appropriately.
Despite the consequences of untreated SA, compliance with CPAP treatment is
often low; within the first 6 months of treatment studies report dropout rates from CPAP
therapy as high as 50% (Bartlett et al., 2013). Although, it is generally agreed that at least
6 hours of uninterrupted sleep is optimal for normal neurobehavioral and general health
functioning (Grandner, Patel, Gehrman, Perlis, & Pack, 2010; Weaver & Chasens, 2007),
adherence has been arbitrarily defined as usage ≥ 4 hr night, 5 days a week (Aloia,
Knoepke, & Lee-Chiong, 2010). In an observational follow-up study of 330 veterans
receiving CPAP therapy, only 49% of the sample met this minimal criterion for
adherence in the first week of therapy (Platt et al., 2009).
The presence of mental health disorders has been found to reduce CPAP
adherence among civilian and veteran populations. Specifically, veterans with PTSD
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and/or a mood disorder have been found to report significantly lower percentages of
nights and hours per night of use at both 1- and 3-month follow-ups when compared to
veterans without any mental health diagnoses (Means, Ulmer, & Edinger, 2010). In a
retrospective study of veterans referred to a sleep disorders clinic from 2005-2009,
adequate CPAP adherence was found in only 41% of veterans having comorbid PTSD
and that was significantly lower than for veterans in a control group. However, even
among veterans without PTSD, the percentage of nights with ≥ 4 hr of use (58.3%) was
still below the recommended threshold (El-Solh, Ayyar, Akinnusi, Relia, & Akinnusi,
2010).
Physical and emotional side effects as well as cognitive factors have been shown
to influence CPAP adherence. Commonly reported physical and emotional barriers
include mask discomfort, machine noise, dryness in the nose and throat, nighttime
awakenings, excessive air pressure, air hunger, panic or claustrophobic reactions to the
nasal mask, and nightmares (El-Solh et al., 2010; Engleman & Wild, 2003; Hirshkowitz,
& Lee-Chiong, 2006). Cognitive factors, such as self-efficacy or the individual’s belief in
his or her ability to successfully engage in a novel behavior, often influence adherence
rates as well (Sawyer et al., 2011). For example, higher initial self-efficacy scores
strongly predicted CPAP adherence across a 6-month follow-up (Bartlett et al., 2013). In
order to create more effective interventions to increase CPAP adherence it is important to
further research these factors.
Interventions
While it is well understood that thorough patient education is essential for
management of any chronic disease, stand-alone educational interventions to increase
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CPAP adherence have not been successful. Across published studies there is a wide range
in intensity of interventions from simply providing written materials, to educational
videos, to telephone support, to in-person groups (Chervin, Theut, Bassetti, & Aldrich,
1997; Fletcher & Luckett, 1991; Golay et al., 2006; Meurice et al., 2007; see Wickwire,
Lettieri, Cairns, & Callop, 2013 for a detailed review). In one study with veterans, 34
patients attended a 2-hour group session that included a video tutorial of proper CPAP
use. Those who attended the session increased their nightly use by approximately 1 h and
gains were maintained across a 3-year follow up (Likar, Panciera, Erickson, & Rounds,
1997). Despite the improvement, at baseline veterans reported an average usage of 5.2 h
night; indicating they already had met the threshold for adequate adherence. Findings
from this study are fairly typical of others examining effects of educational interventions,
wherein improvements in adherence are approximately 1 hr per night, with participants
who tend to experience mild to moderate SA. Thus, the impact of educational
interventions on people with more severe SA remains unknown.
A limited number of studies have explored the efficacy of psychotherapy
interventions for improving CPAP adherence. Aloia et al. (2001) randomized a small
sample of 12 older adults newly diagnosed with SA to two 45-min sessions of either a
Motivational Enhancement Therapy intervention or control. The intervention followed
the principles of MI to address ambivalence over behavior change in a nonconfrontational manner; and included education on the correlates of SA to affect their
decisional balance, a discussion of the pros and cons of CPAP, and problem solving for
any discomfort. The control condition involved a general discussion of sleep architecture.
Significant differences were found at the 12-week follow-up with participants in the
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intervention group reporting greater CPAP use than those in the control (7.8 hr night
versus 4.6 hr night (p < .04) with a large effect size (d = 1.27). Aloia et al. (2007)
expanded their methodology with a three group RTC (n = 160): 1) Motivational
Enhancement Therapy intervention, two 45-min sessions; 2) education intervention, two
45-min sessions discussing the pathophysiology of apnea and its consequences; and 3)
standard clinical care, which provided information about the consequences of SA. Fewer
patients in the intervention conditions discontinued CPAP. However, no differences were
observed with regards to levels of adherence, suggesting the two 45-min sessions may not
provide an adequate amount of treatment to solidify behavioral change and promote
greater adherence over time (Aloia et al., 2007). These results make it difficult to identify
the active parts of treatment and indicate a more thorough evaluation of these
interventions is warranted.
In another study, Richards and colleagues (2007) randomized 100 newly
diagnosed SA patients either to treatment as usual (TAU) or TAU plus a supplemental
intervention. The TAU consisted of a single group education session and a CPAP mask
fitting. The supplemental intervention consisted of two 1-hr CBT group sessions with bed
partners in attendance. The intervention was based on social cognitive theory (focusing
on increasing perceived self-efficacy, outcome expectations, and social support) that
included correcting distorted beliefs, discussing consequences of SA, reviewing the
effectiveness of CPAP treatment, and a demonstration of simple relaxation strategies.
Participants were also shown a 15-min video of other patients describing their success
with CPAP and were given a booklet with information about sleep and SA with a list of
unhelpful thoughts and corresponding appropriate reframes. Participants in the
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intervention condition had higher adherence at a 4-week follow-up compared to TAU
alone (5.4 hr vs 2.5 hr; p < .001).The authors (Bartlett et al., 2013) then altered their
design by randomizing a larger group (n = 206) of patients to a single social cognitive
theory-based CBT group session or an equivalent amount of time devoted to social
interaction. All patients additionally received the TAU education session. CPAP
adherence did not differ between participants in the group intervention and the social
interaction condition (Bartlett et al., 2013). The authors concluded that behavioral
interventions likely need to be more intensive, take into account timing of educational
information, and include other factors, such as self-efficacy.
In a recent Australian study of adults newly diagnosed with OSA, participants
were randomized to either a three-session individual MI intervention or control (45-min
individual educational session). The MI intervention was informed by the Motivational
Enhancement Therapy Manual developed by Miller and colleagues (Miller, Zweben,
DiClemente, & Rychtarik, 1995), with modifications to increase the relevance to the
OSA population (as described in Aloia, Arnedt, Riggs, Hecht, & Borrelli, 2004). Across a
1-month, 2-month, and 3-month follow-up, individuals in the MI condition reported
greater CPAP adherence, with an almost 50% better adherence rate at the 3-month time
point (4.63 hr vs. 3.16 hr; p < .001). Furthermore, these clinically significant gains were
maintained at 12 months (Olsen, Smith, Oei, & Douglas, 2011).
To our knowledge, all prior psychotherapy intervention studies have been
conducted with civilian samples and have consisted of one to three sessions of group or
individual treatment. Despite the variations in content of the interventions, mean CPAP
adherence among intervention groups at follow-up have ranged from only 3.5 hr to 5.4 hr
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per night. Although some studies have reached the adequate care benchmark (> 70%),
research suggests there is a direct dose-response relationship between CPAP use and
improvements; the greater the frequency and duration of use, the better the outcome
(Weaver et al., 2007). Hence, there is a strong need to find more effective interventions
for individuals diagnosed with SA, particularly among veterans.
Aim of Current Study
The present study was designed to compare the effectiveness of treatment as usual
(TAU) to TAU plus a CBT group intervention (created by a psychologist at the Southern
Arizona VA, Haynes, 2013) for increasing CPAP adherence among veterans with SA in a
randomized controlled trial (RCT). This 6-week group integrates cognitive and
behavioral skills to promote increased use of CPAP among veterans. From preliminary
prospective program evaluation information, 7 out of 10 veterans reported an increase in
either number of nights CPAP was used or number of hours CPAP was used (P. Haynes,
personal communication, November 11, 2014). The main hypothesis in the present study
is that veterans who attend the group intervention will increase their CPAP adherence
compared to those in the TAU condition. Secondary hypotheses are that 1) CPAP use
will improve mood, including depression and anxiety symptoms, 2) CPAP use will
improve cognitive function, and 3) self-efficacy will predict CPAP use. Although this
intervention is more time-intensive than treatments in published studies, six weeks is a
standard length of time for psychotherapy groups within the VA system, and we
anticipated it to be a well-tolerated treatment strategy for improving adherence to CPAP.
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Chapter 2
Method
Participants
Participants were veterans at the Memphis Veterans Affairs Medical Center
(VAMC) who were referred for a polysomnography (PSG) study in the Sleep Medicine
clinic. Recruitment occurred face-to-face in the Sleep Medicine clinic when veterans
arrived in the evenings for their PSG study1. Recruitment took place between September,
2014 and February, 2015, with follow-up completed in May 2015. At the time of
recruitment, veterans were asked to participate in a research study that may improve their
ability to use CPAP. They were informed they would be randomly chosen to either attend
a 6-week group or simply attend their regular medical care and if they were in the later
condition they would be invited to attend the group at the conclusion of the study.
Veterans were informed they would be asked to complete a number of questionnaires and
a cognitive screening at the time of enrollment and approximately 3 months later. The
only inclusion criterion was diagnosis of SA. Of the 113 veterans recruited, 65 refused to
participate and 48 were enrolled (13 of which were subsequently found to be ineligible
based on the exclusion criteria). All participants gave informed consent. Eligible
participants were randomly assigned to either treatment as usual (TAU; n = 10) or to

1

Due to higher than anticipated rates of veterans who enrolled and were subsequently
found to be ineligible (i.e., no diagnosis of SA), procedures were altered in December, 2014 to
allow for veterans with diagnosed SA to be recruited from their in-service appointment in the
Sleep Medicine clinic after their PSG study to assure their eligibility prior to being recruited. At
this appointment a staff member informed veterans that they were eligible for a research study
that may help them adjust to using their CPAP. Veterans had the option to provide their contact
information if they were interested, those who did so were contacted via telephone by a member
of the research team to re-assess their interest and answer any initial questions (n = 37). Those
veterans who remained interested were scheduled for an appointment to meet with the researcher
and complete the informed consent and pre-assessment measures (n =13).
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TAU plus the intervention CPAP group (n = 25)2. Figure 1 describes the flow of
participants through the study.
The eligible sample (n = 35) consisted of 34 men and 1 woman. The mean age of
the sample was 52.8 years (SD = 9.4). The majority of the sample was African American
(62.9%), served in the Army (45.7%), and was unemployed (48.6%). The mean service
connection (SC) was 37.1% (SD = 35.4). Mental health diagnoses were unreliable in the
chart and therefore were not taken into account. The sample included participants with all
levels of SA severity (mild to severe) with an average AHI of 34.1 (SD = 29.8) and
average BMI of 33.7 (SD = 4.1). Twenty-two participants were newly diagnosed with
SA, the remaining had prior diagnoses with varying levels of adherence to CPAP.
Demographic characteristics of the sample are reported in Table 1.
Randomization
The principal investigator randomized participants using a sequence generated
with a blocking factor of 2. On evenings, when multiple veterans were enrolled they were
randomized in the order they gave verbal agreement to participate. Participants were
informed of their allocation after they completed the baseline measures. Researchers
completing the post-assessments were not blinded to the condition. Upon completion of
the study, all participants were entered into a drawing for one of two $25 Walmart gift
cards.

2

Due to lower than anticipated eligible enrollment, procedures were altered in February,
2015 that allowed all newly enrolled participants to be allocated to the intervention condition (n =
8) and invited participants who were previously randomized to the TAU condition to participate
in the group intervention (n = 1 completed group; n = 7 declined group).
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Figure 1. Participant Flow Diagram.

14

Table 1
Demographic Characteristics of Sample
Overall (n = 35)

Group (n = 25)

TAU (n = 10)

Variable
Age, y
52.8 (9.4)
53.9 (7.9)
49.9 (12.5)
Males, % (n)
97.1 (34)
96 (24)
100 (10)
Race, % AA (n)
62.9 (22)
76 (19)
30 (3)
Employment
Full-time, % (n)
22.9 (8)
20 (5)
30 (3)
Part-time, % (n)
17.1 (6)
12 (3)
30 (3)
Unemployed, % (n)
48.6 (17)
56 (14)
30 (3)
Branch
Army, % (n)
457 (16)
44 (11)
50 (5)
Navy, % (n)
28.6 (10)
28 (7)
30 (3)
Guard, % (n)
8.6 (3)
4 (1)
20 (2)
Air Force, % (n)
2.9 (1)
12 (3)
Marine, %( n)
2.9 (1)
4 (1)
SC, %
37.1 (35.4)
36.4 (36.7)
39.0 (33.8)
BMI, kg/m2
33.7 (4.1)
34.2 (4.2)
32.7 (3.8)
AHI, events/h
34.1 (29.8)
29.9 (24.8)
44.1 (38.9)
Data are Mean (standard deviation), except for sex, race, employment, and branch,
quoted as percentages with absolute numbers in parentheses. AA, African American; SC,
service connection; BMI, body mass index; AHI, apnea-hypopnea index; TAU, treatment
as usual.

Procedure
Treatment as Usual. All participants attended TAU, which consisted of an inservice appointment following their PSG study (to review their diagnosis, provide CPAP
machine, and give instructions for use) and follow-up appointments in the Sleep
15

Medicine clinic at one month and then every three to six months to review the SmartCard
adherence data from their CPAP machine3. Additionally, participants were encouraged to
contact the Sleep Medicine clinic if they had any equipment problems. Participants in the
TAU condition were scheduled for an appointment with a member of the research study
approximately 3 months following their PSG study to complete the post-assessment
measures4. Once participants completed the post-assessment they were invited to
participate in the intervention group.
Intervention. The CBT group intervention (Haynes, 2013) integrates
psychoeducation with cognitive and behavioral skills to promote greater adherence to the
CPAP treatment. Participants attended six weekly, 50-min sessions with a 1-month
follow-up session5. Participants were provided a treatment manual at the start of first
session that was theirs to keep. Session 1 begins with introductions and learning about the
participants’ experience with SA and then provides education on the causes and
consequences of SA and how CPAP treats the condition. Group members then discuss
pros and cons of CPAP use, practice relaxation (different each session: diaphragmatic
breathing, relaxing imagery, progressive muscle relaxation, passive muscle relaxation,
autogenics), and are assigned homework. The subsequent sessions begin with a review of
3

After the start of the research study there were procedural changes in the Sleep
Medicine clinic and some veterans were given a CPAP machine with an internal modem that
allowed their adherence data to be remotely accessed by a Sleep Medicine technician. For these
participants, their Sleep Medicine follow-up appointments were conducted via telephone.
4

Due to the financial hardship of traveling to the Memphis VA, veterans were given the
option of completing their post-assessment questionnaires via USPS and their cognitive screening
was omitted (n = 2).
5

The initial purpose of the follow-up session was to ensure that the follow-up duration
was equivalent across conditions. Due to inconsistent scheduling by the Sleep Medicine clinic,
this was only implemented for the first group cohort (n = 2). All subsequent participants in the
intervention condition completed the post-assessment at the end of their sixth group session (n
=13).
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previous material, discussion of adherence obstacles and solutions, new content is
presented (see below), and participants end with relaxation and discussion of homework.
Topics covered in the group include avoidance, desensitization to CPAP mask and
machine, reinforcement for goal behavior, cognitive distortions related to CPAP use and
cognitive restructuring, sleep hygiene, and relapse prevention.
CPAP Titration and Apparatus
Participants underwent an in-laboratory PSG study to evaluate SA based on their
AHI index. Any participant who had an AHI > 30 during the first four hours of the PSG
was awakened and asked to put on a CPAP machine for the remainder of the PSG study.
The Sleep Medicine technician then conducted a manual titration of the CPAP pressure to
treat the apnea with a target AHI < 5 per hr of sleep. At the end of the PSG study, those
participants who were started on CPAP attended their in-service appointment and were
provided with a CPAP to take home. All other participants returned to the Sleep
Medicine clinic for their in-service appointment at a later date. All participants were
provided with a REMStar Pro® CPAP (Respironics Inc., Murrysville, PA) device with a
data-storage SmartCard™ that allows usage data to be directly downloaded from the
machine or via a memory key. The data-storage card records run time while the mask is
on the person’s face. A Sleep Medicine technician downloaded the data obtained from the
data-storage cards and entered a note in the participant’s medical chart to indicate
adherence, average pressure, and average AHI6.

6

Due to unforeseen protocol changes in the Sleep Medicine clinic, CPAP adherence data is
currently invalid. Thus, we chose not to use this data as an outcome measure in the present study.
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Measures
All measures were administered at baseline and approximately 3-months
following the participants’ PSG study (with exception of the STTS-R; which was only
given at the follow-up). Demographic information was collected from a review of
participants’ chart in the CPRS system and included age, sex, body mass index, ethnicity,
employment status, military branch, and service connection.
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). The PCL-5
(Weathers et al., 2013) is a 20-item self-report measure designed to assess the 20 DSM-5
symptoms of PTSD using a 5-point Likert scale (0 = Not at All, 4 = Extremely). Veterans
are asked to rate the extent to which they have been bothered by a problem in the past
month (i.e., Trouble remembering important parts of a stressful experience from the
past). Scores range from 0 to 80, with a cut-off score of 38 suggesting clinically
significant PTSD (Weathers et al., 2013). See Appendix A.
Beck Anxiety Inventory (BAI). The BAI (Beck, Epstein, Brown, & Steer, 1988) is
a 21-item self-report measure to assess symptoms of anxiety. Using a 4-point Likert-type
scale ranging from 0 to 3, based on severity of each item, individuals are asked to pick
the statement that best describes how they have been feeling over the past week. Scores
range from 0 to 63, with cutoffs indicating that 0-7 reflects minimal anxiety, 8-15 mild
anxiety, 16-25 moderate anxiety, and 26-63 severe anxiety. This inventory demonstrates
excellent internal consistency (α = .92) and acceptable test-retest reliability over 1 week
(r(81) = .75) (Beck et al., 1988). See Appendix B.
Beck Depression Inventory-II (BDI-II). The BDI-II (Beck, Steer, & Brown, 1996)
is a 21-item self-report measure to assess depression severity in adolescents and adults.
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Using a 4-point Likert-type scale ranging from 0 to 3, based on severity of each item,
individuals are asked to pick the statement that best describes how they have been feeling
over the past two weeks. Scores range from 0 to 63, with cutoffs indicating that 0-13
indicates minimal depression, 14-19 mild depression, 20-28 moderate depression, and 2963 severe depression (Beck et al., 1996). This inventory demonstrates excellent internal
consistency (α = .91; Beck et al., 1996). See Appendix C.
Pittsburgh Sleep Quality Index (PSQI). The PSQI (Buysse et al., 1989) measures
participants’ reported sleep quality over the past month. The PSQI is comprised of 19
items measuring the following seven components: (a) subjective sleep quality, (b) sleep
latency, (c) sleep duration, (d) habitual sleep efficiency, (e) sleep disturbances, (f) use of
sleep medications, and (g) daytime dysfunction. A PSQI score of five or greater, based on
the total scale score, is recommended as the cutoff for detecting sleep impairment in a
range of populations (Buysse, Reynolds, Monk, Berman, & Kupfer., 1989). This index
demonstrates good internal consistency (α = .83; Buysse et al., 1989). See Appendix D.
Epworth Sleepiness Scale (ESS). The ESS (Johns, 1991) is an 8-item, selfadministered questionnaire that measures subjective daytime sleepiness by assessing the
self-reported frequency of falling asleep in various settings. It is rated on a 4-point scale
(0 = would never doze, 3 = high chance of dozing), the total ESS score is the sum of 8
item-scores and can range between 0 and 24. Values >10 are considered to indicate
significant sleepiness (Buysse et al., 2008). Internal consistency for this scale is good
among sleep apnea patients (α = 0.88; Johns, 1992). See Appendix E.
Brief Pain Inventory-Short Form (BPI). The BPI (Cleeland & Ryan, 1994)
assesses both pain severity and pain interference in the last 24 hr (both on a scale of 0 =
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no pain /interference to 10 = pain as bad as bad as you can imagine/completely
interferes). The pain severity subscale score is the mean of the 4 severity questions (Pain
at its worst, least, average, and now). The pain interference subscale score is the mean of
the 7 interference questions (How pain has interfered with your: general activity,
walking, work, mood, enjoyment of life, relations with others, and sleep). The BPI
demonstrates good internal consistency ranging from 0.80 to 0.87 for the four pain
severity items and from 0.89 to 0.92 for the seven interference items (Cleeland & Ryan,
1994). See Appendix F.
Perceived Self-Efficacy Measure for Sleep Apnea (SEMSA). The SEMSA
(Weaver et al., 2003) measures cognitive factors that may influence subsequent CPAP
use, including perception of OSA risk, treatment outcome expectancies, and perceived
treatment self-efficacy. Risk perception is defined as the individual’s perception of health
risks associated with OSA. Treatment outcome expectancies include the individual’s
expectations of certain changes or improvements with CPAP treatment. Treatment selfefficacy is defined as the individual’s belief in their own ability to use CPAP, even when
faced with difficulties (i.e., mask discomfort, noise of device, spouse disturbed by
CPAP). The SEMSA is a 26-item Likert-type scale with three subscales (Perception of
Risk, Outcome Expectancies, and Treatment Self Efficacy). This measure demonstrates
excellent internal consistency (a = 0.92; Weaver et al., 2003). See Appendix G.
Satisfaction with Therapy and Therapist Scale-Revised (STTS-R). The STTS-R
(Oei & Green, 2008) is a 12-item questionnaire with items rated on a 5-point Likert scale
(1 = strongly disagree to 5 = strongly agree) with an additional item that provides a
measure of global improvement (How much did this treatment help with the specific
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problem that led you to therapy) rated from 1 = made things a lot better to 5 = made
things a lot worse. The STTS-R has two subscales, Satisfaction with Therapy and
Satisfaction with Therapist, with higher scores indicating a greater level of patient
satisfaction. The scale has excellent internal consistency (a = .90) and correlates well
with measures of participation in therapy, progress in therapy, and coping ability (Oei &
Green, 2008). See Appendix H.
Trail Making Test (TMT). The TMT is a subtest of the Delis-Kaplan Executive
Functioning System (D-KEFS; Delis, Kaplan, & Kramer, 2001) that has four baseline
conditions (Visual Scanning (1), Number sequencing (2), Letter Sequencing (3), Motor
Speed (5)) that provide normative data and quantify several key components for the one
higher-level executive-function condition (Number-Letter Sequencing (4)). Time is the
primary performance measure with a limit of 150 seconds for the baseline conditions and
240 seconds for the higher-level condition. Participants’ raw score is their completion
time, up to the time limit, which is then converted to an age-normed scaled score with M
= 10 and SD = 3. Additionally, scores on the Number sequencing and Letter Sequencing
conditions are combined to create a composite sequencing score (M = 10 and SD = 3).
The internal consistency for the composite sequencing score is good (range a = .59 to a =
.80 based on age group) (Delis et al., 2001).
Mental Control (MC). The MC is a subscale of the Wechsler Memory Scale III
(WMS; Wechsler, 1997) that assesses memory retrieval and speed of mentally processing
information. The MC subtest is composed of eight timed tasks, such as reciting the
alphabet and to perform novel multitasking skills, such as alternately saying the days of
the week and counting by sixes. Subtest scores reflect accuracy and speed. The subscale
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total score has a range of 0 – 40 and raw scores are converted to an age-corrected scale
score (M = 10, SD = 3). This subscale demonstrates good internal consistency (r = .87) in
a generalizability study (Wechsler, 1997).
Digit Span (DS). The DS is a subtest of the Wechsler Memory Scale III (WMS;
Wechsler, 1997) that includes digit span forward and digit span backward. Digit span
forward is a measure of focused attention and digit span backward is a measure of
working memory. Scores on both forward and backward are combined for the total raw
score (range 0 to 30), which is converted to an age-corrected scale score (M = 10, SD =
3). This subscale demonstrates good internal consistency (r = .86) in a generalizability
study (Wechsler, 1997).
Statistical Analysis
Independent-samples, t-tests, and chi-squared tests were used to check for any
significant differences in demographics and pre-assessment measures between
participants who completed the study (“completers”) and those who dropped out (“drop
outs”) as well as between participants randomized to the group compared to TAU
condition. Descriptive statistics were used to examine the baseline severity of symptoms.
Due to the invalid CPAP adherence data, the statistical analyses reflect what was possible
given the available data. Adjusted hypotheses were that 1) participants in the CPAP
group would show improved scores on the post-assessment compared to those in the
TAU condition and 2) these improvements would be a significant change from their preassessment. One-way analysis of covariance (ANCOVA) tests were conducted to
examine the differences between the TAU and CPAP group participants’ post-assessment
scores controlling for their initial differences using pre-assessment results. Due to the low
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n-values (i.e., groups containing fewer than 15 participants), which may misrepresent the
statistical significance of the scores due to a low degree of freedom value (Green &
Salkin, 2003), we then conducted follow-up paired sample t-tests within conditions to test
for any significant changes from pre- to post-assessment scores. Cohen’s d effect sizes
were also calculated using Morris and DeShon’s (2002) recommendations for withinsubject comparisons. This formula (http://www.cognitiveflexibility.org/effectsize/)
corrects for dependence among means by including the correlation between pre and
posttest means. All statistical analyses were conducted with PASW version 18.0.
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Chapter 3
Results
Descriptive Statistics
In testing for group differences, completers and drop outs differed significantly on
perceived risk of SA (t(30) = 2.2, p = .04; completers M = 23.0, SD = 4.8, drop outs M =
18.9, SD = 5.4) and treatment self-efficacy (t(29) = 2.3, p = .03; completers M = 28.2, SD
= 5.4, drop outs M = 23.7, SD = 4.6) such that participants with greater perceived risk and
higher self-efficacy were more likely to be completers.
Analyses were then conducted to determine if there were significant differences
between participants randomized to the group (n = 25) and TAU (n = 10) conditions on
demographics or pre-assessment measures. Participants differed significantly on race (X2
(1, N = 35) = 6.5, p = .01) such that African American participants were more likely to be
in the group condition. There were also significant differences on sleep impairment
(PSQI t(31) = -2.1, p = .04) and treatment self-efficacy (t(29) = 3.8, p = .001), such that
participants with greater sleep impairment and lower treatment self-efficacy were more
likely to be in the group condition. Demographic characteristics of the sample are shown
in Table 1. Pre- and post-assessment means for TAU and CPAP group conditions are
shown in Table 2.
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Table 2
Pre- and Post-assessment Means and Standard Deviations
Group (n = 14)
Pre-assessment

TAU (n = 7)
PostAssessment
M (SD)

M (SD)
Mental Health a
PCL-5
45.4
(20.5) 40.7
BDI-II
25.4
(10.9) 23.0
BAI
30.2
(17.2) 28.6
BPI-Severity
5.4
(2.5)
5.3
BPI-Interference
5.2
(3.0)
5.7
a
Sleep
PSQI
14.6
(4.1)
13.4
ESS
16.1
(5.2)
15.6
Self-Efficacy b
SEMSA-A
23.6
(4.9)
22.5
SEMSA-B
28.6
(7.0)
29.1
SEMSA-C
25.8
(4.5)
26.7
b
Cognitive
DS
8.9
(2.5)
9.2
MC
9.3
(2.9)
9.8
TMT1
9.6
(2.3)
10.4
TMT2
10.1
(4.0)
10.0
TMT3
9.4
(4.1)
11.3
TMT4
8.4
(4.4)
8.8
TMT5
10.4
(2.6)
10.1
TMT-Sequencing
10.2
(4.2)
11.4
 n = 5 for post-assessment cognitive measures.
a

Pre-Assessment
M (SD)

PostAssessment
M (SD)

(22.1)
(12.3)
(13.9)
(2.9)
(3.4)

33.6
20.9
20.0
4.0
2.7

(18.6)
(10.6)
(13.8)
(3.0)
(3.0)

38.3
18.7
24.9
4.3
3.5

(13.0)
(8.5)
(10.3)
(2.3)
(2.6)

(5.1)
(5.0)

10.0
10.0

(5.3)
(4.1)

8.3
8.6

(3.8)
(5.0)

(5.9)
(6.3)
(5.3)

21.7
31.3
33.1

(4.8)
(5.8)
(3.4)

(3.7)
(3.3)
(4.3)

(2.8)
(2.5)
(3.0)
(3.0)
(2.8)
(4.5)
(2.6)
(3.0)

8.6
9.9
8.6
10.4
9.3
8.6
8.4
10.3

(2.0)
(2.5)
(3.3)
(2.6)
(1.9)
(3.7)
(3.2)
(2.4)

20.3
29.7
31.4

9.2
8.8
8.6
9.4
9.6
10.2
8.6
10.0

lower scores better; b higher scores better.

PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression
Inventory-II; BAI, Beck Anxiety Inventory; BPI, Brief Pain Inventory; PSQ, Pittsburg
Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, Perceived Self-Efficacy
Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment
Self-Efficacy); DS, Digit Span; MC, Mental Control; TMT, Trails Making Test.
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(2.8)
(2.8)
(4.8)
(4.6)
(3.0)
(3.1)
(3.1)
(4.3)

Primary Analyses
ANCOVA tests were conducted to evaluate whether the mean of the dependent
variable (post-assessment scores), adjusted for differences in the covariate (preassessment scores), differed between the TAU and CPAP group conditions. After
adjusting for pre-assessment scores, there was no significant difference between the two
groups on post-assessment scores on severity of PTSD, F (1, 18) = 1.61, p = .22, ηp2 =
.08; depression, F (1, 18) = .09, p = .77, ηp2 = .00; anxiety, F (1, 17) = .07 p = .79, ηp2 =
00; pain, F (1, 18) = .02, p = .90, ηp2 = .00; or pain interference, F (1, 18) = 0.14, p = .71,
ηp2 = 00. Similarly, there was no significant difference between the two groups on the
self-efficacy domains; Perceived Risk, F (1, 18) = 0.42, p = .53, ηp2 = .02; Outcome
Expectancies, F (1, 18) = .01, p = .91, ηp2 = .00; Treatment Self-Efficacy, F (1, 18) = .36,
p = .56, ηp2 = .02. Regarding the cognitive measures, there was a statistically significant
difference between the two groups for Mental Control (F (1, 16) = 4.41, p = .05, ηp2 =
.22) such that participants in the CPAP group condition significantly improved their postassessment Mental Control score compared to TAU. There were no significant
differences between the two groups for any of the other cognitive measures; Digit Span,
F (1, 16) = .01, p = .92, ηp2 = .00; Trails 1, F (1, 16) = .12, p = .74, ηp2 = .00; Trails 2, F
(1, 16) = .37, p = .55, ηp2 = .02; Trails 3, F (1, 16) = 2.43, p = .14, ηp2 = .13; Trails 4, F
(1, 16) = 2.79, p = .12, ηp2 = .15; Trails 5, F (1, 16) = .09, p = .76, ηp2 = .00; Trails
Sequencing, F (1, 16) = 1.90, p = .19, ηp2 = .11. See Table 2 for pre- and post-assessment
means.
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Paired-samples t-tests were then conducted to determine if there were significant
pre- to post-assessment changes on the measures among participants in the TAU and
CPAP group conditions.
In the CPAP group sample, PTSD symptom severity reduced from pre- to postassessment (PCL, t(13)= 1.73, p = .11, d = 0.50); as did severity of depression (t(13)=
1.20, p =.25, d = 0.35) and anxiety (t(12)= 0.80, p = .44, d = 0.20) symptoms. The small
to moderate effect sizes suggest a meaningful improvement in these mental health
symptoms. Similarly, there were non-significant reductions in post-assessment sleep
impairments (t(13)= 0.85, p = .41, d = 0.30) and daytime sleepiness (t(13)= 0.58, p = .57,
d = 0.15). The moderate effect size in reducing overall sleep problems suggests
participants experienced a meaningful change in their sleep. As expected, participants’
outcome expectancies and treatment self-efficacy improved at post-assessment (t(13)= .26, p = .80, d = 0.01; t(13)= -0.90, p = .39, d = 0.26; respectively). Surprisingly,
perceived risk reduced at post-assessment (t(13)= 0.79, p = .44, d = 0.23). Regarding the
cognitive measures, six out of the eight subscales showed non-significant improvement at
the post-assessment (DS, t(13)= -0.64, p = .54, d = 0.18; MC, t(13)= -1.46, p = .17, d =
0.40; TMT1, t(13)= -0.88, p = .35, d = 0.30; TMT3, t(13)= -2.62, p = 0.21, d = 0.66;
TMT4, t(13)= -1.10, p = .29, d = 0.31; TMTS, t(13)= -1.87, p = 0.8, d = 0.50) with effect
sizes suggestive of meaningful improvements. Means and standard deviations presented
in Table 3. Effect sizes are presented in Figure 2 and Figure 3.
In the TAU sample, participants’ PTSD symptom severity increased at the postassessment (t(6)= -0.82, p = .44, d = 0.28) as did their anxiety (t(6)= -0.67, p =.53, d =
0.30) and pain (Severity, t(6)= -0.65, p = .54, d = 0.25; Interference, t(6)= -1.56, p =.17, d
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= 0.60) severity. Depression symptom severity reduced at the post-assessment (t(6)=v.47,
p = .66, d = 0.16). The small to large effect sizes suggest that participants in the TAU
condition may have deteriorated in their mental and physical health functioning after
being diagnosed with SA. Non-significant reductions in total sleep impairment (t(6)= .74,
p = .50, d = 0.22) and daytime sleepiness (t(6)= .78, p = .47, d = 0.33) with small effect
sizes suggest participants’ may have made improvements to their sleep habits.
Participants appeared to decline in their self-efficacy domains at the post-assessment
(Perceived Risk, t(6)= .53, p = .61, d = 0.28; Outcome Expectations, t(6)= .55, p = .60, d
= .024; Treatment Self-Efficacy, t(6)= 1.37, p = .22, d = 0.60). The changes in cognitive
measures were similar to those in the CPAP group condition, five out of the eight
subscales showed improvements at the post-assessment (DS, t(4)= -0.43, p = .69, d =
0.22; TMT1, t(4)= -0.39, p = .72, d = 0.21; TMT3, t(4)= -0.59, p = .59, d = 0.40; TMT4,
t(4)= -1.54, p =.20, d = 0.63; TMT5, t(4)= -2.14, p = .09, d = 1.01). Means and standard
deviations presented in Table 4. Effect sizes are presented in Figure 2 and Figure 3.
Overall, participants responded favorably to the CBT group. Among the
completers, 64% rated their satisfaction with the therapy as “agree” or “strongly agree”
and 93% rated their satisfaction with the therapist as “agree” or “strongly agree.” On the
global improvement question, 67% reported that the treatment “made things a lot better.”
See Figures 4-6.
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Table 3
Paired Samples T-Test, CPAP Group Condition (n = 14)
Variable
Pre M (SD)
a
Mental Health
PCL-5
45.38 (20.46)
BDI-II
25.36 (10.92)
BAI
29.00 (17.87)
BPI-Severity
5.39 (2.50)
BPI-Interference
5.20 (2.98)
Sleep a
PSQI
14.57 (4.09)
ESS
16.07 (5.22)
b
Self-Efficacy
SEMSA-A
23.64 (4.92)
SEMSA-B
28.57 (7.00)
SEMSA-C
25.79 (4.51)
Cognitive b
DS
8.93 (2.53)
MC
9.29 (2.89)
TMT1
9.64 (2.30)
TMT2
10.07 (4.00)
TMT3
9.43 (4.05)
TMT4
8.36 (4.39)
TMT5
10.36 (2.65)
TMT-Sequencing
10.21 (4.21)
Note. Effect sizes reported as Cohen’s d.

Post M (SD)

t

d

40.71 (22.14)
23.00 (12.31)
27.32 (13.76)
5.34 (2.90)
5.73 (3.40)

1.73
1.20
0.80
0.07
-0.64

0.50
0.35
0.20
0.02
0.19

13.36 (5.08)
15.57 (4.98)

0.85
0.58

0.30
0.15

22.50 (5.88)
29.14 (6.30)
26.71 (5.33)

0.79 0.23
-0.26 0.01
-0.90 0.26

9.21 (2.78)
9.79 (2.52)
10.36 (2.95)
10.00 (2.96)
11.29 (2.76)
8.79 (4.53)
10.07 (2.62)
11.36 (2.95)

-.064
-1.46
-0.97
0.86
-2.62
-1.10
0.31
-1.87

0.18
0.40
0.30
0.02
0.66
0.31
0.08
0.50

Note. a lower scores better; b higher scores better.
Note. PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression
Inventory-II; BAI, Beck Anxiety Inventory; BPI, Brief Pain Inventory; PSQI, Pittsburg
Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, Perceived Self-Efficacy
Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment
Self-Efficacy); DS, Digit Span; MC, Mental Control; TMT, Trails Making Test.
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PCL-5

BDI-II

BAI

BPI-S

BPI- I

PSQI

ESS

SEMSA-A SEMSA-B SEMSA-C

Improvement

0.60
0.40
0.20
Group

Deterioration

0.00

TAU

-0.20
-0.40
-0.60

Figure 2. Effect Sizes for Pre- to Post-Assessment Change of Self-Report Measures between Groups
Note. Effect sizes reported as Cohen’s d.
Note. PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression Inventory-II; BAI, Beck Anxiety
Inventory; BPI, Brief Pain Inventory; PSQI, Pittsburg Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA,
Perceived Self-Efficacy Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment Self-Efficacy).
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DS

MC

TMT1

TMT2

TMT3

TMT4

TMT5

TMT- S

Improvement

1.00
0.80
0.60
0.40
0.20

Group

0.00

TAU

Deterioration

-0.20
-0.40
-0.60
-0.80
-1.00
-1.20

Figure 3. Effect Sizes for Pre- to Post-Assessment Change of Cognitive Measures between Groups
Note. Effect sizes reported as Cohen’s d.
Note. DS, Digit Span; MC, Mental Control; TMT, Trails Making Test (S, Sequencing).
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Table 4
Paired Samples T-Test, TAU Condition (n = 7)
Variable
Pre M (SD)
Post M (SD)
Mental Health (lower scores better)
PCL-5
33.57 (18.62) 38.28 (12.98)
BDI-II
20.86 (10.61) 18.71 (8.48)
BAI
20.00 (13.79) 24.91 (10.31)
BPI-Severity
3.96 (2.99)
4.32 (2.29)
BPI-Interference
2.65 (2.97)
3.5 (2.63)
Sleep (lower scores better)
PSQI
10.00 (5.32)
8.42 (3.99)
ESST
10.00 (4.12)
8.57 (4.96)
Self-Efficacy (higher scores better)
SEMSA-A
21.71 (4.75)
20.28 (3.68)
SEMSA-B
31.29 (5.78)
29.71 (3.30)
SEMSA-C
33.14 (3.39)
31.43 (4.28)
Cognitive (higher scores better)

DS
8.80 (2.28)
9.20 (2.77)
MC
9.60 (2.41)
8.80 (2.77)
TMT1
8.00 (3.81)
8.60 (4.83)
TMT2
10.60 (2.79)
9.40 (4.56)
TMT3
9.20 (2.04)
9.60 (2.96)
TMT4
8.00 (4.12)
10.20 (3.11)
TMT5
7.80 (3.42)
8.60 (3.05)
TMT- Sequencing
10.40 (2.61)
10.00 (4.30)
 n = 5 for post-assessment cognitive measures.

t

d

-0.82
0.47
-0.67
-0.65
-1.56

0.28
0.16
0.30
0.25
0.60

0.64
0.78

0.22
0.33

0.53
0.55
1.37

0.28
0.24
0.60

-0.43
2.14
-0.39
0.75
-0.59
-1.54
-2.14
0.34

0.22
1.15
0.21
0.50
0.40
0.63
1.01
0.26

Note. Effect sizes reported as Cohen’s d.
Note. PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression
Inventory-II; BAI, Beck Anxiety Inventory; BPI, Brief Pain Inventory; PSQI, Pittsburg
Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, Perceived Self-Efficacy
Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment
Self-Efficacy); DS, Digit Span; MC, Mental Control; TMT, Trails Making Test.
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Note. Question 13 from SST measure “How much did this treatment help with the
specific problem that led you to therapy?”
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Chapter 4
Discussion
Given the conclusive literature on the negative health consequences of untreated
SA and the ability of CPAP therapy to ameliorate those consequences, finding ways to
promote adherence to CPAP therapy is of the utmost importance. The current study is the
first, to our knowledge, to examine the effectiveness of a CBT group intervention for
CPAP adherence in a veteran sample. We hypothesized that veterans attending the group
would have increased CPAP adherence compared to those in the TAU condition and that
CPAP use would in-turn lead to improvements in mental and physical health symptoms.
Unfortunately, due to inconsistent and likely invalid CPAP adherence reporting in
participant’s medical charts, we chose not to analyze this information. We were,
however, able to test the alternatively proposed hypotheses that participants in the CPAP
group would show improved scores on the post-assessment compared to those in the
TAU condition and that these improvements would be a significant change from their
pre-assessment.
The majority of the eligible sample reported clinically significant symptoms of
PTSD (59%), depression (62%), and anxiety (66%) with half of participants indicating
significant distress in all three mental health domains at baseline. These rates are higher
than previously reported both for an active duty SA sample (Mysliwic et al., 2013;
depression = 22.6%, anxiety =16.8%, PTSD =13.2%) and a veteran SA sample
(Sharafkhaneh et al., 2005; depression = 21.8%, anxiety =16.7%, PTSD =11.9%).
However, both prior studies used more stringent criteria (i.e., ICD-9 codes or diagnostic
codes), as opposed to symptom inventories, which likely accounts for some of the
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difference in rates. As hypothesized, veterans in the group condition reported a reduction
in their symptoms of posttraumatic stress, depression, and anxiety at the post-assessment.
While these reductions were not statistically significant, they did evidence a small to
moderate effect size (d = .20 to .50). This is particular encouraging given participants in
the TAU evidenced increased symptoms of PTSD, anxiety, and pain at the postassessment (d = .25 to .60). The reduction in mean BDI score among the group
participants in the present study is nearly double what has been reported in prior veteran
and civilian samples after initiation of CPAP (Means et al., 2003; Sanchez, Buela-Casal,
Bermudez, & Casas-Maldonado, 2001). Outcomes with anxiety are more varied in the
literature (Saunasmaki & Jehkonen, 2007). Overall, it is likely that a reciprocal
relationship exists between mood and SA that complicates treatment of each disorder
(Ejaz et al., 2011). However, the effect sizes in the present study suggest that the group
participants were able to make a meaningful change in their mental health symptoms and
likely in their quality of life.
In addition to the sample having an average AHI score in the severe range, thirtyone participants (88.6%) had PSQI scores >5, indicating poor sleep quality, and twenty
two participants (62.9%) had ESS scores >10, indicating significant daytime sleepiness.
Participants in both conditions showed improvements in sleep quality and daytime
sleepiness, with small effect sizes despite non-statistically significant changes. This was
surprising, given that in prior studies the ESS was found to be sensitive to chance in nonveteran SA patients who started CPAP (Johns, 1993). Although the standard clinical
understanding is that by treating an individuals’ nocturnal breathing disorder, their sleep
will be improved; there is emerging evidence suggesting that this may not be the case. In
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a large sample of OSA patients who began using PAP adequately, the majority continued
to report disturbed sleep 2 months and 4 months after starting therapy (Stepnowsky,
Zamora, & Edwards, 2014). One potential explanation is that the PSQI and ESS assess
habitual patterns of sleep and sleepiness, which may take longer to improve once the
sleep breathing disorder is treated and/or may require direct intervention simultaneous
with starting CPAP therapy.
Regarding the self-efficacy domains, more than 60% of the participants viewed
most of the possible risks as being associated with SA including being depressed and
having a heart attack. Approximately half the sample did not perceive that falling asleep
while driving or having an accident as related to SA. The majority of the sample linked
the use of CPAP to positive outcomes including feeling better and being more active.
Similarly, the majority of the sample believed that they could overcome the obstacles to
CPAP use presented to them, including having to pay for some of the cost themselves.
These findings suggest that the current sample held more accurate beliefs about OSA and
had higher treatment self-efficacy compared to the initial validation sample of 213
patients from a civilian population (Weaver et al., 2003). In the present study, veterans
who completed the group had a reduction in their perceived risk of SA and improvement
in their CPAP outcome expectations and treatment self-efficacy at the post-assessment.
Although not statistically significant, they demonstrated improvement with small effect
sizes whereas participants in the TAU condition showed declines in their self-efficacy
with small to moderate effect sizes. The reduction in perceived risk is counter intuitive;
however, Olsen and colleagues (2008) reported that in a sample of newly diagnosed OSA
patients a lower perceived risk of negative health consequences was associated with
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greater adherence at 4-month follow-up. Few studies have investigated how interventions
alter self-efficacy domains relating to SA. However, there is a substantial literature on
self-efficacy with other chronic illnesses. Petrie and colleagues (2002) conducted a
prospective, randomized study of 65 patients who experienced their first myocardial
infarction. Half of the sample attended a 3-session intervention, designed to alter their
perceptions about their illness, all participants attended routine care with a rehabilitation
nurse. Patients in the intervention condition reported lower levels of belief that their heart
condition would cause serious consequences (analogous to the perceived risk domain in
the present study) and higher levels of belief that their heart condition could be controlled
(i.e., self-efficacy), and lower levels of distress about their heart condition symptoms
(Petrie, Cameron, Ellis, Buick, & Weinman, 2002). Similarly to the findings in the
present study, the reduction in perceived risk could be explained on an individual level in
that participants’ beliefs that their personal risk of consequence was reduced due to the
increased use of CPAP/treatment.
The cognitive screening measures suggest that the overall sample was functioning
within the average range at baseline (M = 9.33 to 10.09, SD = 2.31 to 3.47). There were
no significant changes at the post-assessment, as would be expected given their baseline
functioning. It is widely accepted that CPAP improves cognition with frequently reported
improvements in the domains of attention, vigilance, memory, and executive functioning
(Aloia, Arnedt, Davis, Riggs, Byrd, 2004; Sánchez et al., 2009; Weaver & Chasens,
2007). However, a recent meta-analysis showed only small improvements in cognitive
functioning after CPAP, specifically in the attention domain (Kylstra et al., 2013). This
meta-analysis implemented more stringent criteria for study inclusion and inclusion of
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weighted study effects compared to previous reviews, which suggests the results may be
more representative of actual functioning. Recent research suggests that although CPAP
use has not yielded conclusive results in improving cognitive function, it has shown
promise in delaying onset of cognitive decline in an elderly sample (Osorio et al., 2015).
While the lack of CPAP adherence data in the present study, prevents us from drawing
conclusions as to the relative value of CPAP for improving cognitive function,
participants in the group condition improved in more subscales (6 out of 8) with stronger
effect sizes at post-assessment compared to the TAU. Clearly, further studies are needed
to determine the potential changes in cognitive function in SA patients using CPAP.
As we anticipated, the six-week group structure appeared to be well-tolerated by
the veteran sample. Of those participants who attended the first group session, the
dropout rate was 16% (n = 4; moved, work obligations, unreliable transportation).
Among completers, participants drove to the Memphis VA from up to 85 miles away.
Overall participants responded favorably to the CBT group, 64% rated their satisfaction
with the therapy as “agree” or better and 93% rated their satisfaction with the therapist as
“agree” or better. On the global improvement question, 93% reported that the treatment
“made things a lot better.” The favorable reports of satisfaction with therapy and therapist
combined with strong effect sizes for self-efficacy scores suggest that the CBT group
intervention helped veterans gain knowledge about the potential benefits of CPAP use
and confidence in their abilities to adhere to the treatment.
Study Limitations
There were numerous limitations in this study that warrant discussion. First and
foremost, was our inability to analyze CPAP adherence data. Our reliance on the
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objective adherence data being collected by a different clinic (Sleep Medicine clinic)
limited our ability to impose reliable collection of that data. Despite their best efforts, the
Sleep Medicine clinic has a high patient volume and is under-staffed, which often
resulted in patients not being scheduled for appointments when intended. Unfortunately,
it was not feasible for key staff in that clinic to devote as much effort into ensuring
patients maintained regular appointments and providing needed data as the researchers
requested. Additionally, the CPAP adherence data recording methods varied between
staff, with some reporting mean hours/minutes of usage and others omitting this type of
information. The time frames over which the adherence data were reported also varied
considerably, often rendering them uninterpretable for our purposes. For example, one
veteran presented for follow-up one week after she completed the group intervention;
however, her compliance was reported across the 10 months since her most recent
follow-up appointment, making it impossible to ascertain if her adherence improved as a
result of the CPAP group. Lastly, midway through the research study the Sleep Medicine
clinic introduced new CPAP models that allowed for remote data access. Unfortunately,
as common with new technology, there were many “kinks” in the system and the data
downloaded via the remote modem was unreliable through the duration of the study.
Another limitation is that the recruitment took place in a clinic other than where
the intervention occurred, which negatively impacted enrollment and likely reduced
patient “buy-in”. Although we believe we had strong “buy-in” from the staff in the Sleep
Medicine clinic, marketing the study to the potential participants was difficult at times. A
protocol change, which allowed for the Sleep Medicine clinic technician to tell veterans
about the study when they attended their in-service appointment, seemed to provide
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confidence to the veterans that the study may be of benefit to them. The relatively high
number of missing values for the cognitive measures at the post-assessment for TAU
participants was a further limitation. This occurred when it would have been a financial
hardship for veterans to travel to the VA (they all agreed to complete the questionnaires
via the mail).
Several limitations are a result of conducting a research study within the VA
system. We had a very liberal inclusion criterion (i.e., diagnosis of SA) and no other
exclusion criteria, which makes it difficult to draw conclusions as to the factors that may
predict adherence. However, this is congruent with actual clinical practice where the goal
is to include any individual who could potentially benefit from intervention. Additionally,
having to conduct the study across various clinics is in-part imposed by the structure of
hospital and care systems, which were historically organized to respond rapidly to acute
illness with the patient’s role being largely passive (Wagner et al., 2001). As a result, care
for chronic conditions such as hypertension, congestive heart failure, and diabetes is often
suboptimal. The difficulty in the present study of recruitment and obtaining necessary
outcome data to evaluate study outcomes all speak to these realities.
A strength to the study is that it is the first attempt, to our knowledge, at
conducting a CBT group intervention for CPAP adherence in a veteran sample. We are
thus able to provide a description of a representative sample of veterans with SA to add to
the literature on this chronic illness. Effect sizes suggest that participants who attended
the CPAP group intervention had moderate reductions in severity of PTSD (d = 0.50) and
depression (d = 0.35) symptoms and lesser reductions in anxiety (d = 0.20) symptoms.
Additional improvements include moderate reduction in total sleep impairment (d =
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0.30), a small increase in treatment-self efficacy (d = 0.26) and varied improvements in
several cognitive domains (d = 0.18 to 0.66). Overall, the group was well tolerated and
helped veterans make behavioral changes necessary for long-term adherence to CPAP
therapy.
Implications for Research and Practice
We learned several valuable lessons about what to incorporate into future work.
Recruiting and delivering high-quality chronic illness care demands planning and the
coordinated actions of multiple caregivers (Wagner et al., 2001). As we underestimated
the volume of recruiting effort and the rate of attrition, future studies should anticipate
and take this into account when conducting studies with veteran samples. Including a
veteran’s Sleep Medicine technician aided in assuring veterans that the study was
credible. Historically low CPAP adherence rates, likely indicate a failure in these
domains. In the present study, it was very clear that the standard information provided in
the Sleep Medicine clinic was insufficient to promote adequate CPAP use. For example,
numerous participants who presented to the first group session still did not understand
what SA was or how CPAP treated the condition, even after they were provided with the
basic facts regarding SA. As has been previously shown, education alone is often not
sufficient to promote lasting behavioral change; however, Sleep Medicine personnel
likely do not have the resources to provide more extensive education or behavioral
training. Therefore, future interventions should encourage more communication and
collaboration between disciplines and clinics. Creating a feedback loop where
participants are asked about group topics at their Sleep Medicine appointments may help
solidify their behavior change.
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As the present study provided initial descriptions of a veteran sample interested
in an intervention for using CPAP more regularly, future studies may find this of value
when designing investigations to account for individual differences, such as illness
duration, cultural background, age, gender, and dispositional variables (e.g., optimism,
self-efficacy). These variables are likely to be important to consider as possible
moderators in the development of interventions and identifying subgroups most at-risk
for low adherence (Nicassio, Meyerowitz, & Kerns, 2004). Additionally, the patient’s bed
partner can play an important role in promoting adherence, with prior studies reporting
less than half of participants would use CPAP if it disturbed their bed partner’s sleep. In a
recent review, a dyadic perspective to CPAP use was suggested that recognized the
nature of spousal involvement in CPAP adherence (Ye et al., 2015). Lastly, prior
suggestions for management of chronic illness should apply to individuals with SA
including having the confidence and skills to manage their condition, having appropriate
treatments to assure optimal disease control, and having continuous follow-up (Wagner et
al., 2001). Interventions, such as the CBT group in the present study are necessary to help
veterans adequately manage their SA.
Conclusion
High rates of SA among military populations combined with the chronic nature of
the disease and serious health complication indicate that SA is a major medical problem
(Brook, 2010; Mysliwiec et al., 2013). The gold standard for treatment—CPAP
therapy—has been demonstrated to reduce hypertension, risk of cardiovascular events
including stroke, and even death across a variety of populations (Collop, 2007; Marin et
al., 2005). Unfortunately, CPAP adherence is often below recommended guidelines
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(Bartlett et al., 2013). A variety of interventions have been explored to address this lack
of adherence with mixed results. The present study was found to be well tolerated among
a small veteran sample and results suggest that it was beneficial in helping veterans
increase their self-efficacy towards CPAP therapy and as a result, their CPAP use may
have led to reductions in various mental and physical health problems. This is a
developing field of literature that requires more investigation into barriers to CPAP use
within in a military population and specific moderators/predictors of individuals who are
at risk for non-adherence.
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